| Symbol |
Name |
|
ABCD2
|
ATP-binding cassette, sub-family D (ALD), member 2
|
|
ACAN
|
aggrecan
|
|
ACE2
|
angiotensin I converting enzyme 2
|
|
ACTA1
|
actin, alpha 1, skeletal muscle
|
|
ADAM10
|
ADAM metallopeptidase domain 10
|
|
ADAM19
|
ADAM metallopeptidase domain 19
|
|
ADAM9
|
ADAM metallopeptidase domain 9
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
ALB
|
albumin
|
|
ALPL
|
alkaline phosphatase, liver/bone/kidney
|
|
ANO1
|
anoctamin 1, calcium activated chloride channel
|
|
ANXA1
|
annexin A1
|
|
ANXA4
|
annexin A4
|
|
APCS
|
amyloid P component, serum
|
|
APOA5
|
apolipoprotein A-V
|
|
APOB
|
apolipoprotein B
|
|
APOBEC3F
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3F
|
|
APOE
|
apolipoprotein E
|
|
APOH
|
apolipoprotein H (beta-2-glycoprotein I)
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AQP1
|
aquaporin 1 (Colton blood group)
|
|
ARMS2
|
age-related maculopathy susceptibility 2
|
|
ATXN3
|
ataxin 3
|
|
BAX
|
BCL2-associated X protein
|
|
BDKRB2
|
bradykinin receptor B2
|
|
BIRC3
|
baculoviral IAP repeat containing 3
|
|
BMP2
|
bone morphogenetic protein 2
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BST2
|
bone marrow stromal cell antigen 2
|
|
CASP1
|
caspase 1, apoptosis-related cysteine peptidase
|
|
CBFA2T3
|
core-binding factor, runt domain, alpha subunit 2; translocated to, 3
|
|
CD46
|
CD46 molecule, complement regulatory protein
|
|
CD55
|
CD55 molecule, decay accelerating factor for complement (Cromer blood group)
|
|
CD59
|
CD59 molecule, complement regulatory protein
|
|
CD79B
|
CD79b molecule, immunoglobulin-associated beta
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDX2
|
caudal type homeobox 2
|
|
CFH
|
complement factor H
|
|
CNR1
|
cannabinoid receptor 1 (brain)
|
|
COL6A5
|
collagen, type VI, alpha 5
|
|
COL6A6
|
collagen, type VI, alpha 6
|
|
CRB1
|
crumbs family member 1, photoreceptor morphogenesis associated
|
|
CRTC2
|
CREB regulated transcription coactivator 2
|
|
CSF1R
|
colony stimulating factor 1 receptor
|
|
CSTB
|
cystatin B (stefin B)
|
|
CTAG1B
|
cancer/testis antigen 1B
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTSG
|
cathepsin G
|
|
CTSL
|
cathepsin L
|
|
CXCL2
|
chemokine (C-X-C motif) ligand 2
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CYP2B6
|
cytochrome P450, family 2, subfamily B, polypeptide 6
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
CYP3A
|
cytochrome P450, family 3, subfamily A
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
CYP4F11
|
cytochrome P450, family 4, subfamily F, polypeptide 11
|
|
CYP4F12
|
cytochrome P450, family 4, subfamily F, polypeptide 12
|
|
CYP4F2
|
cytochrome P450, family 4, subfamily F, polypeptide 2
|
|
CYP4F3
|
cytochrome P450, family 4, subfamily F, polypeptide 3
|
|
DNMT3B
|
DNA (cytosine-5-)-methyltransferase 3 beta
|
|
DRD4
|
dopamine receptor D4
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERCC1
|
excision repair cross-complementation group 1
|
|
ERCC2
|
excision repair cross-complementation group 2
|
|
EZR
|
ezrin
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
F7
|
coagulation factor VII (serum prothrombin conversion accelerator)
|
|
FCGR2B
|
Fc fragment of IgG, low affinity IIb, receptor (CD32)
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FMR1
|
fragile X mental retardation 1
|
|
FOSL1
|
FOS-like antigen 1
|
|
FOXP3
|
forkhead box P3
|
|
GATA4
|
GATA binding protein 4
|
|
GDF5
|
growth differentiation factor 5
|
|
GDI1
|
GDP dissociation inhibitor 1
|
|
GH1
|
growth hormone 1
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GIPR
|
gastric inhibitory polypeptide receptor
|
|
GLUD2
|
glutamate dehydrogenase 2
|
|
GSS
|
glutathione synthetase
|
|
GUCY2D
|
guanylate cyclase 2D, membrane (retina-specific)
|
|
GYPC
|
glycophorin C (Gerbich blood group)
|
|
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)
|
|
H2AFX
|
H2A histone family, member X
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-C
|
major histocompatibility complex, class I, C
|
|
HNF1B
|
HNF1 homeobox B
|
|
HSD17B1
|
hydroxysteroid (17-beta) dehydrogenase 1
|
|
HSPG2
|
heparan sulfate proteoglycan 2
|
|
HTR2A
|
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled
|
|
IGF2
|
insulin-like growth factor 2
|
|
IL15
|
interleukin 15
|
|
IL17A
|
interleukin 17A
|
|
IL18
|
interleukin 18
|
|
IL1B
|
interleukin 1, beta
|
|
IL2
|
interleukin 2
|
|
IL20
|
interleukin 20
|
|
IL22
|
interleukin 22
|
|
IL6
|
interleukin 6
|
|
ITGAV
|
integrin, alpha V
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
JUN
|
jun proto-oncogene
|
|
KISS1
|
KiSS-1 metastasis-suppressor
|
|
KL
|
klotho
|
|
KLF4
|
Kruppel-like factor 4 (gut)
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
LDLR
|
low density lipoprotein receptor
|
|
LGMN
|
legumain
|
|
LOXL1
|
lysyl oxidase-like 1
|
|
MAGEA4
|
melanoma antigen family A4
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MGAT2
|
mannosyl (alpha-1,6-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase
|
|
MMP28
|
matrix metallopeptidase 28
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MYD88
|
myeloid differentiation primary response 88
|
|
MYOCD
|
myocardin
|
|
NES
|
nestin
|
|
NF2
|
neurofibromin 2 (merlin)
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NPY
|
neuropeptide Y
|
|
NR4A1
|
nuclear receptor subfamily 4, group A, member 1
|
|
NRP1
|
neuropilin 1
|
|
OSM
|
oncostatin M
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PLD1
|
phospholipase D1, phosphatidylcholine-specific
|
|
PLK2
|
polo-like kinase 2
|
|
POLRMT
|
polymerase (RNA) mitochondrial (DNA directed)
|
|
PRF1
|
perforin 1 (pore forming protein)
|
|
PTGDR
|
prostaglandin D2 receptor (DP)
|
|
PTGER2
|
prostaglandin E receptor 2 (subtype EP2), 53kDa
|
|
PTGER3
|
prostaglandin E receptor 3 (subtype EP3)
|
|
PTGER4
|
prostaglandin E receptor 4 (subtype EP4)
|
|
PTGS1
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTX3
|
pentraxin 3, long
|
|
RGS1
|
regulator of G-protein signaling 1
|
|
RPS10
|
ribosomal protein S10
|
|
S100B
|
S100 calcium binding protein B
|
|
SEMA3A
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A
|
|
SGK1
|
serum/glucocorticoid regulated kinase 1
|
|
SIX1
|
SIX homeobox 1
|
|
SLC11A2
|
solute carrier family 11 (proton-coupled divalent metal ion transporter), member 2
|
|
SLC1A6
|
solute carrier family 1 (high affinity aspartate/glutamate transporter), member 6
|
|
SLC22A4
|
solute carrier family 22 (organic cation/zwitterion transporter), member 4
|
|
SLC22A5
|
solute carrier family 22 (organic cation/carnitine transporter), member 5
|
|
SLC25A17
|
solute carrier family 25 (mitochondrial carrier; peroxisomal membrane protein, 34kDa), member 17
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
SLC2A3
|
solute carrier family 2 (facilitated glucose transporter), member 3
|
|
SLC40A1
|
solute carrier family 40 (iron-regulated transporter), member 1
|
|
SLC6A3
|
solute carrier family 6 (neurotransmitter transporter), member 3
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLCO1B1
|
solute carrier organic anion transporter family, member 1B1
|
|
SLCO1B3
|
solute carrier organic anion transporter family, member 1B3
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SNCB
|
synuclein, beta
|
|
SOCS3
|
suppressor of cytokine signaling 3
|
|
SOST
|
sclerostin
|
|
TBXA2R
|
thromboxane A2 receptor
|
|
TECTA
|
tectorin alpha
|
|
TFAM
|
transcription factor A, mitochondrial
|
|
TGFBR1
|
transforming growth factor, beta receptor 1
|
|
TNF
|
tumor necrosis factor
|
|
TNFSF15
|
tumor necrosis factor (ligand) superfamily, member 15
|
|
TOP1
|
topoisomerase (DNA) I
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
TP53
|
tumor protein p53
|
|
TRPM3
|
transient receptor potential cation channel, subfamily M, member 3
|
|
TYMP
|
thymidine phosphorylase
|
|
UCN
|
urocortin
|
|
VEGFA
|
vascular endothelial growth factor A
|
